A nanoparticle-based formulation of the anticancer drug pazopanib, which inhibits VEGFR1 and VEGFR2, shows promise as a disease-modifying drug for osteoarthritis.

中文翻译：

---

基于纳米颗粒的帕唑帕尼在 OA 中显示出前景

抗癌药物帕唑帕尼的纳米颗粒制剂可抑制 VEGFR1 和 VEGFR2，有望成为治疗骨关节炎的疾病缓解药物。